|
1
|
Kalliomaki JL and Vastamaki M: Chronic
diffuse oedema of the rheumatoid hand: A sign of local lymphatic
involvement. Ann Rheum Dis. 27:167–169. 1968.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Salvarani C, Macchioni PL, Veneziani M,
Rossi F, Lodi L, Baricchi R, Boiardi L and Portioli I: Upper limb
lymphedema in psoriatic arthritis. J Rheumatol. 17:273–274.
1990.PubMed/NCBI
|
|
3
|
Mulherin DM, FitzGerald O and Bresnihan B:
Lymphedema of the upper limb in patients with psoriatic arthritis.
Semin Arthritis Rheum. 22:350–356. 1993.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kiely PD, Bland JM, Joseph AE, Mortimer PS
and Bourke BE: Upper limb lymphatic function in inflammatory
arthritis. J Rheumatol. 22:214–217. 1995.PubMed/NCBI
|
|
5
|
Salvarani C, Cantini F, Olivieri I,
Niccoli L, Senesi C, Macchioni L, Boiardi L and Padula A: Distal
extremity swelling with pitting edema in psoriatic arthritis:
Evidence of 2 pathological mechanisms. J Rheumatol. 26:1831–1834.
1999.PubMed/NCBI
|
|
6
|
Bohm M, Riemann B, Luger TA and Bonsmann
G: Bilateral upper limb lymphoedema associated with psoriatic
arthritis: A case report and review of the literature. Br J
Dermatol. 143:1297–1301. 2000.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Diez-Porres L, Munoz-Fernandez S, Aguado
P, Alonso M and Martin-Mola E: Remitting seronegative symmetrical
synovitis with pitting oedema as the first manifestation of
psoriatic arthropathy. Rheumatology (Oxford). 41:1333–1335.
2002.PubMed/NCBI
|
|
8
|
Yamamoto T and Nishioka K: Psoriasis
arthropathy and lymphedema. J Dermatol. 29:812–814. 2002.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Quarta L, Corrado A, d'Onofrio F, Maruotti
N and Cantatore FP: Two cases of distal extremity swelling with
pitting oedema in psoriatic arthritis: The different pathological
mechanisms. Rheumatol Int. 30:1367–1370. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Almodovar R, Zarco P, Quiros FJ and
Mazzucchelli R: Infliximab treatment efficacy in lymphoedema
associated with ankylosing spondylitis. Rheumatology (Oxford).
43(1456)2004.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lubrano E, Perrotta FM, Scriffignano S,
Coates LC and Helliwell P: Sustained very low disease activity and
remission in psoriatic arthritis patients. Rheumatol Ther.
6:521–528. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lekpa FK, Economu-Dubosc A, Fevre C,
Claudepierre P and Chevalier X: Efficacy of etanercept in
lymphedema associated with psoriatic arthritis. J Rheumatol.
36:207–208. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Taylor W, Gladman D, Helliwell P,
Marchesoni A, Mease P, Mielants H and Group CS: Classification
criteria for psoriatic arthritis: Development of new criteria from
a large international study. Arthritis Rheum. 54:2665–2673.
2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Helliwell PS, FitzGerald O, Fransen J,
Gladman DD, Kreuger GG, Callis-Duffin K, McHugh N, Mease PJ, Strand
V, Waxman R, et al: The development of candidate composite disease
activity and responder indices for psoriatic arthritis (GRACE
project). Ann Rheum Dis. 72:986–991. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gan Y, Sun Y, Jin J, Wang Y, Chen J, Chung
Y, Li X and Ye H: bFGF could be a biomarker of malignancy in
RS3PE syndrome: An ambispective single-center cohort
analysis of 51 patients. Arthritis Res Ther. 23(261)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kerschbaumer A, Fenzl KH, Erlacher L and
Aletaha D: An overview of psoriatic arthritis-epidemiology,
clinical features, pathophysiology and novel treatment targets.
Wien Klin Wochenschr. 128:791–795. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Gladman DD and Brockbank J: Psoriatic
arthritis. Expert Opin Investig Drugs. 9:1511–1522. 2000.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gottlieb AB, Bakewell C and Merola JF:
Musculoskeletal imaging for dermatologists: Techniques in the
diagnosis and management of psoriatic arthritis. Dermatol Ther
(Heidelb). 11:1199–1216. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Szczerkowska-Dobosz A, Krasowska D,
Bartosinska J, StawczykMacieja M, Walczak A, Owczarczyk-Saczonek A,
Reich A, Batycka-Baran A, Czajkowski R, Dobrucki IT, et al:
Pathogenesis of psoriasis in the ‘omic’ era. Part IV. Epidemiology,
genetics, immunopathogenesis, clinical manifestation and treatment
of psoriatic arthritis. Postepy Dermatol Alergol. 37:625–634.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kenzaka T: The relationship between
remitting seronegative symmetrical synovitis with pitting edema and
vascular endothelial growth factor and matrix metalloproteinase 3.
Intern Med. 59:1021–1022. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Fearon U, Griosios K, Fraser A, Reece R,
Emery P, Jones PF and Veale DJ: Angiopoietins, growth factors, and
vascular morphology in early arthritis. J Rheumatol. 30:260–268.
2003.PubMed/NCBI
|
|
22
|
Veale DJ and Fearon U: The pathogenesis of
psoriatic arthritis. Lancet. 391:2273–2284. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bucaloiu ID, Olenginski TP and Harrington
TM: Remitting seronegative symmetrical synovitis with pitting edema
syndrome in a rural tertiary care practice: A retrospective
analysis. Mayo Clin Proc. 82:1510–1515. 2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kimura M, Tokuda Y, Oshiawa H, Yoshida K,
Utsunomiya M, Kobayashi T, Deshpande GA, Matsui K and Kishimoto M:
Clinical characteristics of patients with remitting seronegative
symmetrical synovitis with pitting edema compared to patients with
pure polymyalgia rheumatica. J Rheumatol. 39:148–153.
2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gisserot O, Cremades S, Landais C, Leyral
G, Bernard P and de Jaureguiberry JP: RS3PE revealing recurrent
non-Hodgkin's lymphoma. Joint Bone Spine. 71:424–426.
2004.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chiappetta N and Gruber B: Remitting
seronegative symmetrical synovitis with pitting edema associated
with acute myeloid leukemia. J Rheumatol. 32:1613–1614.
2005.PubMed/NCBI
|
|
27
|
Tunc SE, Arslan C, Ayvacioglu NB, Sahin M,
Akkus S and Yorgancigil H: Paraneoplastic remitting seronegative
symmetrical synovitis with pitting edema (RS3PE syndrome): A report
of two cases and review of the literature. Rheumatol Int.
24:234–237. 2004.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Schaeverbeke T, Fatout E, Marce S, Vernhes
JP, Halle O, Antoine JF, Lequen L, Bannwarth B and Dehais J:
Remitting seronegative symmetrical synovitis with pitting oedema:
Disease or syndrome? Ann Rheum Dis. 54:681–684. 1995.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Olivieri I, Padula A, Favaro L, Pierro A,
Oranges GS and Ferri S: Dactylitis with pitting oedema of the hand
in longstanding ankylosing spondylitis. Clin Rheumatol. 14:701–704.
1995.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Cantini F, Niccoli L, Olivieri I, Barozzi
L, Pavlica P, Bozza A, Macchioni PL, Padula AA and Salvarani C:
Remitting distal lower extremity swelling with pitting oedema in
acute sarcoidosis. Ann Rheum Dis. 56:565–566. 1997.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Okumura T, Tanno S, Ohhira M and Nozu T:
The rate of polymyalgia rheumatica (PMR) and remitting seronegative
symmetrical synovitis with pitting edema (RS3PE) syndrome in a
clinic where primary care physicians are working in Japan.
Rheumatol Int. 32:1695–1699. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Joseph AD, Kumanan T, Aravinthan N and
Suganthan N: An unusual case of remitting seronegative symmetrical
synovitis with pitting edema: Case report and literature review.
SAGE Open Med Case Rep. 8(2050313X20910920)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Cantini F, Salvarani C, Olivieri I,
Macchioni L, Niccoli L, Padula A, Falcone C, Boiardi L, Bozza A,
Barozzi L and Pavlica P: Distal extremity swelling with pitting
edema in psoriatic arthritis: A case-control study. Clin Exp
Rheumatol. 19:291–296. 2001.PubMed/NCBI
|
|
34
|
Ku DD, Zaleski JK, Liu S and Brock TA:
Vascular endothelial growth factor induces EDRF-dependent
relaxation in coronary arteries. Am J Physiol. 265:H586–H592.
1993.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Arima K, Origuchi T, Tamai M, Iwanaga N,
Izumi Y, Huang M, Tanaka F, Kamachi M, Aratake K, Nakamura H, et
al: RS3PE syndrome presenting as vascular endothelial growth factor
associated disorder. Ann Rheum Dis. 64:1653–1655. 2005.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Baumgartner I, Rauh G, Pieczek A, Wuensch
D, Magner M, Kearney M, Schainfeld R and Isner JM: Lower-extremity
edema associated with gene transfer of naked DNA encoding vascular
endothelial growth factor. Ann Intern Med. 132:880–884.
2000.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Eder L, Aydin SZ, Kaeley GS, Maksymowych
WP and Ostergaard M: Options for Assessing Joints and Entheses in
Psoriatic Arthritis by Ultrasonography and Magnetic Resonance
Imaging: How to Move Forward. J Rheumatol Suppl. 94:44–47.
2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Crespo-Rodriguez AM, Sanz Sanz J, Freites
D, Rosales Z, Abasolo L and Arrazola J: Role of diagnostic imaging
in psoriatic arthritis: How, when, and why. Insights Imaging.
12(121)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Szuba A, Shin WS, Strauss HW and Rockson
S: The third circulation: Radionuclide lymphoscintigraphy in the
evaluation of lymphedema. J Nucl Med. 44:43–57. 2003.PubMed/NCBI
|
|
40
|
Kleinert S, Feuchtenberger M, Kneitz C and
Tony HP: Psoriatic arthritis: Clinical spectrum and diagnostic
procedures. Clin Dermatol. 25:519–523. 2007.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Kohm M, Burkhardt H and Behrens F:
Anti-TNFalpha-therapy as an evidence-based treatment option for
different clinical manifestations of psoriatic arthritis. Clin Exp
Rheumatol. 33 (Suppl 5):S109–S114. 2015.PubMed/NCBI
|
